Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dextromethorphan and Memantine for Amphetamine-type Stimulants Use Disorder
NCT03729128Phase 2Completed
- Start
- Jul 2018
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dextromethorphan, memantine in amphetamine-type stimulant use disorder. Started Jul 2018; status: completed.
02
Drugs
dextromethorphanmemantine
03
Conditions
amphetamine-type stimulant use disorder
Beyond the preview
Go deeper on NCT03729128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03729128.